A1 Refereed original research article in a scientific journal

2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors




AuthorsPätsi Henri T, Kilpeläinen Tommi P, Auno Samuli, Dillemuth Pyry MJ, Arja Khaled, Lahtela-Kakkonen Maija K, Myöhänen Timo T, Wallén Erik AA

PublisherAmer Chemical Soc

Publication year2021

JournalACS Medicinal Chemistry Letters

Journal name in sourceACS MEDICINAL CHEMISTRY LETTERS

Journal acronymACS MED CHEM LETT

Volume12

Issue10

First page 1578

Last page1584

Number of pages7

ISSN1948-5875

eISSN1948-5875

DOIhttps://doi.org/10.1021/acsmedchemlett.1c00399

Web address https://pubs.acs.org/doi/10.1021/acsmedchemlett.1c00399

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/67752755


Abstract
Different five-membered nitrogen-containing heteroaromatics in the position of the typical electrophilic group in prolyl oligopeptidase (PREP) inhibitors were investigated and compared to tetrazole. The 2-imidazoles were highly potent inhibitors of the proteolytic activity. The binding mode for the basic imidazole was studied by molecular docking as it was expected to differ from the acidic tetrazole. A new putative noncovalent binding mode with an interaction to His680 was found for the 2-imidazoles. Inhibition of the proteolytic activity did not correlate with the modulating effect on protein-protein-interaction-derived functions of PREP (i.e., dimerization of alpha-synuclein and autophagy). Among the highly potent PREP inhibiting 2-imidazoles, only one was also a potent modulator of PREP-catalyzed alpha-synuclein dimerization, indicating that the linker length on the opposite side of the molecule from the five-membered heteroaromatic is critical for the disconnected structure-activity relationships.

Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 16:17